Download PDF
Horm Metab Res 2010; 42(13): 987-990
DOI: 10.1055/s-0030-1265224
Short Communication

© Georg Thieme Verlag KG Stuttgart · New York

Pioglitazone has Direct Effects on Insulin Sensitivity and Intracellular Lipid Content in L6 Skeletal Muscle Cells

M. Kranebitter[*] , A. Niederwanger[*] , T. Tatarczyk1 , C. Ciardi1 , R. Al-Zoairy1 , J. R. Patsch1 , M. T. Pedrini1
  • 1Department of Internal Medicine I, Innsbruck Medical University, Innsbruck, Austria
Further Information

Publication History

received 23.06.2010

accepted 02.09.2010

Publication Date:
13 October 2010 (online)

Also available at
   Permissions and Reprints
Preview

Abstract

Using L6 skeletal muscle cell line, rendered insulin resistant by incubation with triglyceride-rich lipoproteins (TGRLs), we sought to answer the question whether pioglitazone has direct effects on this cell line. Incubation of L6 cells with TGRLs led to an increase in the intramyocellular triglyceride content. Moreover, TGRLs led to a reduction in insulin-stimulated glycogen content and GSK-3 phoshorylation. All these changes induced by TGRLs could be antagonized by incubation of L6 cells with pioglitazone. The PPAR-γ antagonist GW9662 reversed the pioglitazone effects. We conclude that pioglitazone has direct insulin-sensitizing effects on the L6 skeletal muscle cell line, which are paralleled by a reduction in intramyocellular triglyceride accumulation.

References

  • 1 Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. Nature. 2001;  409 307-312
    Search in Google Scholar
  • 2 Yonemitsu S, Nishimura H, Shintani M, Inoue R, Yamamoto Y, Masuzaki H, Ogawa Y, Hosoda K, Inoue G, Hayashi T, Nakao K. Diabetes. 2001;  50 1093-1101
    Search in Google Scholar
  • 3 Kubota N, Terauchi Y, Kubota T, Kumagai H, Itoh S, Satoh H, Yano W, Ogata H, Tokuyama K, Takamoto I, Mineyama T, Ishikawa M, Moroi M, Sugi K, Yamauchi T, Ueki K, Tobe K, Noda T, Nagai R, Kadowaki T. J Biol Chem. 2006;  281 8748-8755
    Search in Google Scholar
  • 4 Pedrini MT, Kranebitter M, Niederwanger A, Kaser S, Engl J, Debbage P, Huber LA, Patsch JR. Diabetologia. 2005;  48 756-766
    Search in Google Scholar
  • 5 Niehaus WG, Samuelsson B. Eur J Biochem. 1968;  6 126-130
    Search in Google Scholar
  • 6 Wills ED. Biochem J. 1969;  113 315-324
    Search in Google Scholar
  • 7 Yanfeng C, Ying L, Yanwen W, Ying W, Changhao S. Metabolism. 2009;  58 1694-1702
    Search in Google Scholar
  • 8 Yki-Jarvinen H. N Engl J Med. 2004;  351 1106-1118
    Search in Google Scholar
  • 9 LeBrasseur NK, Kelly M, Tsao TS, Farmer SR, Saha AK, Ruderman NB, Tomas E. Am J Physiol Endocrinol Metab. 2006;  291 E175-E181
    Search in Google Scholar
  • 10 Thomson DM, Winder WW. Acta Physiol (Oxf). 2009;  196 147-154
    Search in Google Scholar

1 These authors contributed qually to this work.

Correspondence

M. T. PedriniMD 

Department of Internal

Medicine I

Medical University of Innsbruck

Anichstrasse 35

6020 Innsbruck

Austria

Phone: +43/512/504 23326

Fax: +43/512/504 28539

Email: michael.pedrini@i-med.ac.at